Sacubitril-Valsartan: A Cost-Effective Solution...

By Staff Writer

October 7, 2023

A New Class IA Recommendation for Heart Failure Treatment Heart failure, a major cause of hospital admissions in the U.S., comes with high morbidity, mortality, and financial costs. Recent advanc...